두필루맙 치료가 아토피 피부염이 있는 어린이의 비병변 및 병변 피부에서 상피 장벽을 회복시킨다.

Cork et al. (Thu,)는 이 질문을 연구했다.

www.synapsesocial.com/papers/69a75afbc6e9836116a2183c — DOI: https://doi.org/10.1016/j.anai.2026.01.008

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood· 2019 · 116 citations
2. Impaired skin barrier and allergic sensitization in early infancy· 2021 · 64 citations
3. Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events· 2022 · 92 citations
4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis· 2018 · 666 citations
5. Skin biomarkers predict development of atopic dermatitis in infancy· 2022 · 82 citations